Compounders Research Compare

Sintx Technologies, Inc.(SINT)

Medical - Devices · Salt Lake City, UT

$2.18Daily change unavailable

Delayed quote: Oct 6, 2026, 3:50 PM EDT

About Sintx Technologies, Inc.

Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.

Salt Lake City, UT

32 employees

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Eric K. Olson

View full financials

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T19:53:57.070Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:53:57.070Z.

Quote observation: 2026-10-06T19:50:20.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 13,859,631
TTM free cash flow · period ending 2026-06-30: -10,336,000

FMP input reference: e88a9ce363f502b6754b19b8a4115a17c58c771a6bc05fe10e5aff55a47e2c9d

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

SINT Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

SINT Competitors' Price/FCF Ratio

Sintx Technologies, Inc.

Current

Market Cap

$13.86M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Obsidian Therapeutics Inc.

Market Cap

$13.84M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Pulsenmore Ltd. Ordinary Shares

Market Cap

$14.17M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Optimi Health Corp.

Market Cap

$13.48M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Vyome Holdings, Inc.

Market Cap

$14.46M

Price/FCF Ratio

27.57

TTM Avg

28.16

3Y Avg

28.16

5Y Avg

28.16

Citius Pharmaceuticals, Inc.

Market Cap

$13.31M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IN8bio, Inc.

Market Cap

$13.14M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Cytosorbents Corporation

Market Cap

$12.63M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Karyopharm Therapeutics Inc.

Market Cap

$14.78M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Pasithea Therapeutics Corp.

Market Cap

$14.97M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Sintx Technologies, Inc. (SINT)	$13.86M	N/A	N/A	N/A	N/A
Obsidian Therapeutics Inc. (OBX)vs ›	$13.84M	N/A	N/A	N/A	N/A
Pulsenmore Ltd. Ordinary Shares (PLSM)vs ›	$14.17M	N/A	N/A	N/A	N/A
Optimi Health Corp. (OPTH)vs ›	$13.48M	N/A	N/A	N/A	N/A
Vyome Holdings, Inc. (HIND)vs ›	$14.46M	27.57	28.16	28.16	28.16
Citius Pharmaceuticals, Inc. (CTXR)vs ›	$13.31M	N/A	N/A	N/A	N/A
IN8bio, Inc. (INAB)vs ›	$13.14M	N/A	N/A	N/A	N/A
Cytosorbents Corporation (CTSO)vs ›	$12.63M	N/A	N/A	N/A	N/A
Karyopharm Therapeutics Inc. (KPTI)vs ›	$14.78M	N/A	N/A	N/A	N/A
Pasithea Therapeutics Corp. (KTTA)vs ›	$14.97M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Growth Operating Margin All Metrics